Drug profile · INN
quetiapine fumarate
QUETIAPINE FUMARATE
quetiapine fumarate (QUETIAPINE FUMARATE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — quetiapine fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 4
- Data quality
- 0.89
Quick answer
quetiapine fumarate (QUETIAPINE FUMARATE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is quetiapine fumarate?
quetiapine fumarate (QUETIAPINE FUMARATE) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for quetiapine fumarate?
QUETIAPINE FUMARATE is a marketed brand name for quetiapine fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of quetiapine fumarate?
quetiapine fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.